Gujarat Terce Laboratories Limited (GUJTERC.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹40.00 (+3.39%) as of
Key statistics
- Market cap
- 311.65M
- P/E (TTM)
- 15.09
- EPS (TTM)
- 2.65
- Dividend yield
- 0.00%
- 52-week range
- 29.00 – 50.00
- Beta
- 0.95
- Revenue (TTM)
- 456.22M
- Profit margin
- 4.53%
- Volume
- 26.54k
About Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, and Codimol brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ahmedabad, India
- Employees
- 234
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.